Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120747094 | 12074709 | 4 | F | 201410 | 20160628 | 20160212 | 20160701 | EXP | PHHY2010CA80150 | NOVARTIS | 73.44 | YR | F | Y | 0.00000 | 20160702 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120747094 | 12074709 | 1 | PS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 10 MG, EVERY 4 WEEKS | U | 21008 | 10 | MG | |||||||
| 120747094 | 12074709 | 2 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 20 MG, EVERY 4 WEEKS | U | 21008 | 20 | MG | |||||||
| 120747094 | 12074709 | 3 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 30 MG, EVERY 4 WEEKS | U | 21008 | 30 | MG | |||||||
| 120747094 | 12074709 | 4 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 20 MG, QMO | U | 21008 | 20 | MG | /month |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 120747094 | 12074709 | 1 | Carcinoid tumour of the caecum |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 120747094 | 12074709 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 120747094 | 12074709 | Asthenia | |
| 120747094 | 12074709 | Asthenopia | |
| 120747094 | 12074709 | Blood pressure increased | |
| 120747094 | 12074709 | Body temperature decreased | |
| 120747094 | 12074709 | Cataract | |
| 120747094 | 12074709 | Decreased appetite | |
| 120747094 | 12074709 | Hypoaesthesia | |
| 120747094 | 12074709 | Inflammation | |
| 120747094 | 12074709 | Injection site erythema | |
| 120747094 | 12074709 | Injection site mass | |
| 120747094 | 12074709 | Injection site pain | |
| 120747094 | 12074709 | Injection site swelling | |
| 120747094 | 12074709 | Insomnia | |
| 120747094 | 12074709 | Musculoskeletal pain | |
| 120747094 | 12074709 | Ocular discomfort | |
| 120747094 | 12074709 | Pain in extremity | |
| 120747094 | 12074709 | Pulse abnormal |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 120747094 | 12074709 | 1 | 20100927 | 0 | ||
| 120747094 | 12074709 | 4 | 20160208 | 0 |